Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
Major depressive disorder (MDD) is a common psychiatric disorder with multifactorial aetiology and complex pathophysiology. Despite availability of various pharmacological and non-pharmacological therapeutic strategies, treatment resistant depression (TRD) remains a significant challenge with specif...
Enregistré dans:
Auteur principal: | Naghmeh Nikkheslat |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2369bc529d63484dbb35b814e26d76e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Immunoregulation and antidepressant effect of ketamine
par: Zhang Nan, et autres
Publié: (2021) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
par: Wei Zheng, et autres
Publié: (2021) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
par: F Kheirkhah, et autres
Publié: (2010) -
EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
par: Muhammad Siddique Kakar, et autres
Publié: (2020) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
par: Mateusz Kowalczyk, et autres
Publié: (2021)